Calcium and the saga of the binders: Accumulating controversy, or building consensus?

International Urology and Nephrology

Volumn 40, Issue 4, 2008, Pages 1009-1014

  Goldsmith, David J A ^a   Covic, Adrian ^b  

^a GUY S HOSPITAL   (United Kingdom)

^b C I PARHON NATIONAL INSTITUTE OF ENDOCRINOLOGY   (Romania)

Author keywords

Calcium; End stage renal disease; Phosphate binders; Sevelamer; Vascular calcification

Indexed keywords

ALBUMIN; ATORVASTATIN; C REACTIVE PROTEIN; CALCIUM; CALCIUM ACETATE; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARICALCITOL; PHOSPHATE BINDING AGENT; SEVELAMER; VITAMIN D;

ALBUMIN BLOOD LEVEL; BLOOD VESSEL CALCIFICATION; BONE BIOPSY; BONE DISEASE; BONE METABOLISM; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; DISEASE SEVERITY; DRUG MECHANISM; EDITORIAL; HEMODIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTHYROIDISM; OUTCOME ASSESSMENT; PREVALENCE; PROTEIN BLOOD LEVEL; RENAL PROTECTION; SOFT TISSUE CALCIFICATION; VITAMIN SUPPLEMENTATION;

CALCINOSIS; CALCIUM; CHELATING AGENTS; CLINICAL TRIALS AS TOPIC; HUMANS; HYPERPHOSPHATEMIA; PHOSPHATE-BINDING PROTEINS; POLYAMINES; RENAL DIALYSIS;

EID: 56249118355     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9477-x     Document Type: Editorial

References (22)

1. Goldsmith DJ, Gusbeth-Tatomir P, Covic A (2007) Vascular calcification - a new window on the cardiovascular system: Role of agents used to manipulate skeletal integrity. Semin Dial 20(2):158-169. doi: 10.1111/ j.1525-139X.2007.00254.x
2. Goldsmith D, Ritz E, Covic A (2004) Vascular calcification: A stiff challenge for the nephrologist: Does preventing bone disease cause arterial disease? Kidney Int 66:1315-1333. doi: 10.1111/ j.1523-1755.2004.00895.x
3. Braun J, Oldendorf M, Moshage W et al (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401. doi: 10.1016/ S0272-6386(96)90363-7
4. Russo D, Miranda I, Ruocco C (2007) The progression of coronary artery calcification in predialysis patients on sevelamer or calcium carbonate. Kidney Int 72(10):1255-1261. doi: 10.1038/sj.ki.5002518
5. Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252. doi: 10.1046/j.1523-1755.2002.00434.x
6. Block GA, Spiegel DM, Ehrlich J et al (2005) Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68:1815-1824. doi: 10.1111/ j.1523-1755.2005.00600.x
7. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM (2007) Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71:438-441. doi: 10.1038/sj.ki.5002059
8. Nikolov IG, Joki N, Maizel J et al (2006) Pleiotropic effects of the non-calcium phosphate binder sevelamer. Kidney Int 70:S16-S23. doi: 10.1038/sj.ki.5001994
9. Qunibi WY, Moustafa M, Muenz LR et al (2008) A 1 year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2). Am J Kidney Dis 51(6):952-965
10. Qunibi WY, Hootkins RE, McDowell LL et al (2004) Treatment of hyperphosphatemia in hemodialysis patients: The Calcium Acetate Renagel Evaluation (CARE Study). Kidney Int 65(5):1914-1926. doi: 10.1111/ j.1523-1755.2004.00590.x
11. Wanner C, Krane V, März W et al (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353:238-248. doi: 10.1056/NEJMoa043545
12. Kestenbaum B (2008) Calcification in CKD. No closer to the cure. Am J Kidney Dis 51(6):877-879
13. Cademartiri F (2006) Is calcium the key for the assessment of progression/regression of coronary artery disease? Heart 92:1187-1188. doi: 10.1136/hrt.2006.089573
14. Ferreira A, Frazao JM, Monier-Faugere MC et al (2008) Effects of sevelamer and calcium carbonate on renal osteodystrophy in haemodialysis patients. J Am Soc Nephrol 19(2):405-412. doi: 10.1681/ASN.2006101089
15. London GM, Marty C, Marchais SJ et al (2004) Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15:1943-1951. doi: 10.1097/01.ASN.0000129337.50739.48
16. London GM, Marchais SV, Guerin AP et al (2008) Association of bone activity, calcium load, aortic stiffness and calcifications in ESRD. J Am Soc Nephrol 19:1827-1835. doi: 10.1681/ASN.2007050622
17. Moe S, Drüeke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945-1953. doi: 10.1038/sj.ki.5000414
18. Covic A, Gusbeth-Tatomir P, Goldsmith DJA (2008) Negative outcome studies in end-stage renal disease--how dark are the storm clouds. Nephrol Dial Transplant 23(1):56-61. doi: 10.1093/ndt/gfm706
19. Yuen D, Pierratos A, Richardson RM, Chan CT (2006) The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 21:1407-1412. doi: 10.1093/ndt/gfl021
20. Demer LL, Tintut Y (2008) Vascular calcification: Pathobiology of a multi-faceted disease. Circulation 117:2938-2948. doi: 10.1161/ CIRCULATIONAHA.107.743161
21. Spasovski GB (2007) Bone health and vascular calcification relationships in chronic kidney disease. Int Urol Nephrol 39:1209-1216
22. Kovesdy CP, Kalantar-Zadeh K (2008) Bone and mineral disorders in pre-dialysis CKD. Int Urol Nephrol 40:427-440